Access Biotechnology — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Pandion TherapeuticsJan 2018
BiotechCambridge, US
Jo Viney(Executive Officer)Rahul Kakkar(Executive Officer, Director)Anthony Coyle(Executive Officer, Director)Christopher Fuglesang(Director)Donald Frail(Director)Daniel Becker(Director)
Co-investorsPolaris PartnersVersant Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.